Global BGM and CGM Market Growth 2025-2031

Global BGM and CGM Market Growth 2025-2031

The global BGM and CGM market size is predicted to grow from US$ 16730 million in 2025 to US$ 30300 million in 2031; it is expected to grow at a CAGR of 10.4% from 2025 to 2031.

Blood glucose monitoring is the use of a glucose meter for testing the concentration of glucose in the blood. Particularly important in diabetes management, a blood glucose test is typically performed by piercing the skin (typically, on the finger) to draw blood, then applying the blood to a chemically active disposable 'test-strip'. The test is usually referred to as capillary blood glucose.

Global key players of BGM and CGM include Abbott, Dexcom, Roche, Lifescan, Ascensia, etc. The top five players hold a share about 80%. North America is the world's largest market for BGM and CGM and holds a share about 45%, followed by Europe and Asia-Pacific, with share about 28% and 20%, separately. In terms of product type, CGM is the largest segment, accounting for a share about 61%. In terms of application, Household is the largest field with a share about 82 percent.

LP Information, Inc. (LPI) ' newest research report, the “BGM and CGM Industry Forecast” looks at past sales and reviews total world BGM and CGM sales in 2024, providing a comprehensive analysis by region and market sector of projected BGM and CGM sales for 2025 through 2031. With BGM and CGM sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BGM and CGM industry.

This Insight Report provides a comprehensive analysis of the global BGM and CGM landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BGM and CGM portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BGM and CGM market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BGM and CGM and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BGM and CGM.

This report presents a comprehensive overview, market shares, and growth opportunities of BGM and CGM market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
BGM
CGM

Segmentation by Application:
Household
Hospital
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Abbott
Dexcom
Roche
Lifescan
Ascensia
Medtronic
ARKRAY
Sinocare
I-SENS
Terumo
B. Braun
Acon
Yicheng
Omron
SD Biosensor
77 Elektronika
Yuwell
Osang Healthcare
AgaMatrix
Senseonics Holdings

Key Questions Addressed in this Report

What is the 10-year outlook for the global BGM and CGM market?

What factors are driving BGM and CGM market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do BGM and CGM market opportunities vary by end market size?

How does BGM and CGM break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.